Timeline

Timothée Bruel
Group Leader
26 Sep 2024
publication

Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.

Read more
19 Jul 2024
publication

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.

Read more
13 Dec 2023
publication

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

Read more
14 Jun 2023
publication

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.

Read more
01 Jun 2023
publication

Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.

Read more
14 Feb 2023
publication

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

Read more
24 Jan 2023
team

Antiviral Activities of Antibodies

Read more
17 Nov 2022
publication

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.

Read more
05 Oct 2022
publication

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Read more
01 Sep 2022
publication

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

Read more
27 Aug 2022
publication

IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies.

Read more
08 Jul 2022
publication

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination.

Read more
04 Jul 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Read more
17 Jun 2022
news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Read more
01 Jun 2022
publication

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.

Read more
04 May 2022
publication

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

Read more
12 Mar 2022
publication

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Read more
02 Feb 2022
publication

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells.

Read more
01 Feb 2022
publication

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Read more
01 Jan 2022
publication

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.

Read more
01 Nov 2021
publication

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.

Read more
17 Sep 2021
publication

Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.

Read more
01 Sep 2021
publication

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

Read more
18 Aug 2021
news

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

Read more
01 Aug 2021
publication

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Read more
22 Jul 2021
news

SARS-CoV-2 : induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance

Read more
08 Jul 2021
publication

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Read more
08 Jun 2021
news

Covid-19, un an après : persistance des anticorps protecteurs et réduction significative du risque de réinfection

Read more
18 May 2021
publication

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.

Read more
01 Apr 2021
publication

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Read more
01 Jan 2021
publication

Characteristics Associated with Olfactory and Taste Disorders in COVID-19.

Read more
01 Dec 2020
publication

Syncytia formation by SARS-CoV-2-infected cells.

Read more
02 Sep 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Read more
01 Sep 2020
publication

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Read more
05 Feb 2020
publication

Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.

Read more
15 Oct 2019
project

3D Pasteur

Read more
01 Jun 2019
publication

Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice.

Read more
01 Aug 2018
publication

A human immune system mouse model with robust lymph node development.

Read more
23 Feb 2018
publication

Correction: Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection.

Read more
13 Oct 2017
publication

HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels

Read more
14 Jun 2017
publication

Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.

Read more
01 May 2017
publication

Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity

Read more
15 Mar 2017
publication

Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.

Read more
15 Mar 2017
publication

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

Read more
25 Jan 2017
publication

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies

Read more
10 Oct 2016
publication

CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge

Read more
12 Sep 2016
publication

[Antibodies that kill HIV-1-infected cells]

Read more
03 Mar 2016
news

Antibodies capable of eliminating HIV-infected cells

Read more
03 Mar 2016
publication

Elimination of HIV-1-infected cells by broadly neutralizing antibodies

Read more
01 Jan 2016
publication

Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.

Read more
01 Jul 2015
publication

SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells

Read more
11 May 2015
team

Virus and Immunity

Read more
14 Jan 2015
publication

Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses

Read more
26 Nov 2014
publication

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread

Read more
30 Jan 2014
publication

Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques

Read more
12 Jan 2012
publication

Porcine colon explants in the study of innate immune response to Entamoeba histolytica

Read more
21 Dec 2011
publication

Towards the establishment of a porcine model to study human amebiasis

Read more
13 Apr 2010
publication

Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy

Read more
06 Jan 2010
publication

Epithelial induction of porcine suppressor of cytokine signaling 2 (SOCS2) gene expression in response to Entamoeba histolytica

Read more